​

IGM Biosciences (IGMS) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

IGM Biosciences Revenue Highlights

Latest Revenue (Y)

$2.68M

Latest Revenue (Q)

$143.62M

IGM Biosciences Revenue by Period

IGM Biosciences Revenue by Year

DateRevenueChange
2024-12-31$2.68M25.77%
2023-12-31$2.13M99.25%
2022-12-31$1.07M100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31--

IGM Biosciences generated $2.68M in revenue during NA 2024, up 25.77% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

IGM Biosciences Revenue by Quarter

DateRevenueChange
2025-06-30$143.62M28682.16%
2025-03-31$499.00K21.12%
2024-12-31$412.00K-20.16%
2024-09-30$516.00K-58.85%
2024-06-30$1.25M152.31%
2024-03-31$497.00K-23.66%
2023-12-31$651.00K27.90%
2023-09-30$509.00K13.62%
2023-06-30$448.00K-14.18%
2023-03-31$522.00K40.32%
2022-12-31$372.00K12.39%
2022-09-30$331.00K-9.56%
2022-06-30$366.00K100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31--

IGM Biosciences generated $143.62M in revenue during Q2 2025, up 28682.16% compared to the previous quarter, and up 28897.99% compared to the same period a year ago.

IGM Biosciences Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
SWTXSpringWorks Therapeutics$191.59M$61.55M
STOKStoke Therapeutics$36.55M$13.82M
IGMSIGM Biosciences$2.68M$143.62M
CGEMCullinan Therapeutics--
AKROAkero Therapeutics--
ALXOALX Oncology--
EWTXEdgewise Therapeutics--
DYNDyne Therapeutics--
MLYSMineralys Therapeutics--

IGMS Revenue FAQ

What is IGM Biosciences’s yearly revenue?

IGM Biosciences's yearly revenue for 2024 was $2.68M, representing an increase of 25.77% compared to 2023. The company's yearly revenue for 2023 was $2.13M, representing an increase of 99.25% compared to 2022. IGMS's yearly revenue for 2022 was $1.07M, representing an increase of 100.00% compared to 2021.

What is IGM Biosciences’s quarterly revenue?

IGM Biosciences's quarterly revenue for Q2 2025 was $143.62M, a 28682.16% increase from the previous quarter (Q1 2025), and a 11353.19% increase year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $499K, a 21.12% increase from the previous quarter (Q4 2024), and a 0.40% increase year-over-year (Q1 2024). IGMS's quarterly revenue for Q4 2024 was $412K, a -20.16% decrease from the previous quarter (Q3 2024), and a -36.71% decrease year-over-year (Q4 2023).

What is IGM Biosciences’s revenue growth rate?

IGM Biosciences's revenue growth rate for the last 3 years (2022-2024) was 150.61%, and for the last 5 years (2020-2024) was 0%.